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Characterization of Dendritic Cells
that Induce Tolerance and T Regulatory 1
Cell Differentiation In Vivo
a direct effect on T cells but involved a modification of
APC function (Wakkach et al., 2001).
Dendritic cells (DCs) are professional APCs, special-
ized in the capture, processing, and transport of the
antigen to lymphoid organs where they sensitize anti-
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Hoˆpital de l’Archet gen-specific naive T cells (Banchereau and Steinman,
1998). DCs also have an important role in the control2 TxCell
Bat. ARC of the adaptive immune response (Moser and Murphy,
2000). Recently, several studies have also reported aRoute de Street Antoine de Ginestie`re
06200 Nice role for DCs in the induction of peripheral tolerance
(Steinman et al., 2000). In vitro experiments have demon-France
strated that DCs with an immature phenotype induce the
differentiation of anergic/suppressive T cells (Jonuleit et
al., 2000). On the basis of these data, the tolerogenicSummary
potential of DCs has been proposed to be correlated
with the absence of activation of DCs with proinflamma-Active suppression is mediated by a subpopulation of
CD4 T cells that prevents autoimmunity. However, tory signals. On the other hand, in vivo experiments have
suggested that induction of T cell tolerance is mediatedthe mechanisms involved in their differentiation in vivo
are currently under intensive research. Here we show by a subtype of specialized DCs (Akbari et al., 2001).
Therefore, though experimental evidence supports thethat in vitro culture of bone marrow cells in the pres-
ence of IL-10 induces the differentiation of a distinct existence of tolerogenic DCs, their nature is still largely
unknown.subset of dendritic cells with a specific expression of
CD45RB. These CD11clowCD45RBhigh DCs are present In this study, we demonstrate the ability of IL-10 to
induce the differentiation of a distinct subset of DCsin the spleen and lymph nodes of normal mice and are
significantly enriched in the spleen of IL-10 Tg mice. which express specifically the CD45RB marker and se-
crete IL-10. This CD11clowCD45RBhigh DC subset wasThese natural or in vitro-derived DCs display plas-
macytoid morphology and an immature-like pheno- also isolated from the spleen of IL-10 transgenic (Groux
et al., 1999) or BALB/c and C57Bl/6 mice. They displaytype, and secrete high levels of IL-10 after activation.
OVA peptide-pulsed CD11clowCD45RBhigh DCs specifi- an immature-like phenotype even after in vitro activation
with LPS or CpG oligodeoxynucleotides (ODN). In addi-cally induce tolerance through the differentiation of
Tr1 cells in vitro and in vivo. Our findings identify a tion, CD11clowCD45RBhigh DCs induce the differentiation
of Tr1 cells, and adoptive transfer of peptide-pulsednatural DC subset that induces the differentiation of
Tr1 cells and suggest their therapeutic use. CD11clowCD45RBhigh DCs induced OVA-specific unre-
sponsiveness in recipient mice.
Introduction
Results
The induction of tolerance is critical for the maintenance
of immune homeostasis. In the thymus, central tolerance IL-10 Induces the Differentiation of a Distinct
is a well-established mechanism that involves deletion DC Subset
of self-reactive T cells. In the periphery, the mechanisms We have shown that IL-10 induces the differentiation of
involved include the induction of cell death, the develop- Tr1 cells through an indirect effect (Wakkach et al.,
ment of a state of unresponsiveness (anergy) of T cells, 2001). We therefore analyzed the effect of IL-10 on the
and active suppression by T regulatory (Tr) cells (Groux differentiation of DCs from bone marrow cells cultured
et al., 1997). However, the mechanisms by which Tr cells in the presence of GM-CSF and TNF- (preliminary ex-
arise in vivo and exert their immunoregulatory effects periments have shown that the presence of TNF- did
remain to be defined and are the subject of intensive not influence the phenotype and function of DCs; how-
investigations. ever, it helped to expand the yield and viability of DC
We have previously shown that both human and populations (data not shown). The addition of IL-10 at
mouse CD4 T cells, repeatedly stimulated in the pres- day 0 of the culture induces the differentiation of a popu-
ence of IL-10, differentiate into a new subset of CD4 lation of DCs with a low expression of CD11c and a
T cells, termed Tr1 (T regulatory 1) cells (Groux et al., high expression of CD45RB (Figure 1A). After FACS cell
1997). These T cells have a poor proliferative response, sorting based on the specific expression of CD11c and
secrete high levels of IL-10, and regulate Th1 and Th2 CD45RB, in vitro-differentiated CD11clowCD45RBhigh DCs
responses in vitro and in vivo (Cottrez et al., 2000; Groux displayed plasmacytoid morphology with a smooth
et al., 1997; Cong et al., 2002). We also showed that the plasma membrane and an eccentric nucleus (Figure 1B,
effect of IL-10 on the differentiation of Tr1 cells was not 1) in contrast to CD11chighCD45RB DCs (Figure 1B, 3).
After further maturation with LPS, both populations ac-
quired morphology of fully mature DCs (Figures 1B, 2*Correspondence: groux@unice.fr
3These authors contributed equally to this work. and 4). A population of DCs with a plasmacytoid mor-
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Figure 1. IL-10 Induces the Differentiation of CD11clowCD45RBhigh DCs
(A) Bone marrow cells were cultured with GM-CSF and TNF- in the presence or absence of IL-10 (10 or 500 ng/ml) as indicated for 6 days
and then activated for 24 hr with LPS. BM-DCs were analyzed for CD11c and CD45RB expression. Data represent the results of one
representative experiment out of seven.
(B) DCs were sorted according to the expression of CD11c and CD45RB as indicated in Figure 1A. Sorted cells were cytocentrifuged and
stained with May Gru¨ndwald Giemsa. (1) CD11clowCD45RBhigh DCs after 6 days of differentiation. (2) CD11clowCD45RBhigh DCs after LPS activation.
(3) CD11chighCD45RB DCs after 6 days of differentiation. (4) CD11chighCD45RB DCs after LPS activation.
(C) Sorted DCs were stained with the indicated FITC-antibodies. Sorted DCs were also stimulated with LPS (1 g/ml) for 24 hr, stained with
the indicated mAbs, and reanalyzed. Open histogram dotted lines represent cells stained with isotype-matched control mAbs. Data represent
the results of one representative experiment out of three.
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Figure 2. Identification of IL-10-Derived DCs In Vivo
(A) Splenic DCs from IL-10 transgenic, IL-10 /, and BALB/c or C57Bl/6 mice were isolated and enriched by cell depletion with a cocktail of
antibodies containing anti-B220, anti-Gr1, and anti-CD3 mAbs, and surface expression of CD11c was analyzed by flow cytometry.
(B) DC preparations enriched by cell depletion with a cocktail of antibodies containing anti-B220, anti-Gr1, and anti-CD3 mAbs were isolated
from the spleen of IL-10 transgenic, IL-10 /, and BALB/c or C57Bl/6 mice and analyzed for expression of CD11c-cy5 and CD45RB-PE. The
percentages of cells in the different quadrants are indicated. Results are typical of over ten experiments.
(C) Sorted CD11clowCD45RBhigh (1) and CD11chighCD45RB (3) DCs isolated from the spleen of BALB/c mice were cytocentrifuged and stained
with May-Gru¨nwald-Giemsa. Sorted CD11clowCD45RBhigh (2) and CD11chighCD45RB (4) DCs were also stimulated with LPS (1 g/ml) in the
presence of GM-CSF for 24 hr.
(D) Enriched DC preparations from IL-10 Tg, BALB/c, or C57Bl/6 mice were FACS sorted based on CD11clowCD45RBhigh or CD11chighCD45RB
expression and reanalyzed as shown. Sorted cells were then stained with the FITC-labeled third marker and analyzed by cytofluorometry
(open histograms). Sorted DCs were also stimulated with LPS (1 g/ml) in the presence of GM-CSF for 24 hr, stained with the indicated mAbs,
and reanalyzed (closed histograms). Dotted histograms represent isotype-matched control mAbs.
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Figure 3. Phenotypic Characterization and
Cytokine Secretion of the CD11clowCD45
RBhigh/B220 DC Subset
(A) To compare CD11clowCD45RBhigh popula-
tions with previously described plasmacytoid
cells expressing low levels of CD11c but ex-
pressing the B220 and Gr1 markers, analyses
were performed on DC preparations enriched
by cell depletion with a cocktail of antibodies
containing anti-CD19 and anti-CD3 mAbs.
DCs isolated from the spleen of BALB/c or
C57Bl/6 mice were analyzed for expression
of CD11c-cy5 and B220-PE.
(B) Enriched DC preparations from BALB/c
mice were sorted based on CD11clowB220,
CD11clowB220, or CD11chigh expression as
indicated, and staining for the third marker
was analyzed on the different populations.
Dotted histograms represent isotype-matched
control mAbs.
(C) Similar sorted cells were stained with the
FITC-labeled third marker and analyzed by
cytofluorometry (open histograms). Sorted
DCs were also stimulated with CpG ODN (1
M) in the presence of GM-CSF for 24 hr,
stained with the indicated mAbs, and reana-
lyzed (closed histograms). Dotted histograms
represent isotype-matched control mAbs.
(D and E) Cytokine profiles of the different DC
subpopulations. (D) In a first set of experi-
ments, CD11chighCD45RB (white bars) and
CD11clowCD45RBhigh (black bars) DC subsets
were sorted out based on CD11c and
CD45RB expression from splenic DC popula-
tions enriched with a cocktail containing anti-
CD3, anti-B220, and anti-Gr1 mAbs. Sorted
CD11chighCD45RB (white crosshatched
bars) and CD11clowCD45RBhigh (black cross-
hatched bars) cells were also stimulated with
LPS (1 g/ml) in the presence of GM-CSF for
24 hr. Values are expressed as fold increased
expression above a negative sample and rep-
resent mean SD of three separate sample
experiments. (E) DC populations were also
prepared with a cocktail containing anti-CD3
and anti-CD19 mAbs and sorted according
to CD11c and B220 expression. Cells were
not stimulated (gray bars) or stimulated with
CpG ODN (1 M, white bars) or LPS (1 g/
ml, black bars), and supernatants were ana-
lyzed at 24 hr for secretion of IFN- or 48 hr
for IL-10 measurements.
phology that expresses low levels of CD11c has already express B220 and Gr-1 (Figure 1C), which have been
described as specific markers of plasmacytoid DCs,been described (Asselin-Paturel et al., 2001; O’Keeffe
et al., 2002). However, CD11clowCD45RBhigh DCs do not suggesting that they represent distinct populations of
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DCs. Analysis of costimulatory and MHC class II mole- current protocols for mouse DC isolation, a cocktail of
antibodies containing anti-B220 and anti-Gr-1 in the en-cule expression revealed low expression levels of CD80,
CD86, and I-A molecules on CD11clowCD45RBhigh DCs richment step. We therefore performed other experi-
ments with another cocktail of depleting antibodies(Figure 1C) as compared to CD11chighCD45RB DCs.
Maturation of DCs with LPS did not modify the pheno- (anti-CD3 and anti-CD19). The expression analysis of
CD11c and B220 on this new DC preparation revealedtype of CD11clowCD45RBhigh DCs (Figure 1C) whereas it
enhanced expression of CD80, CD86, and I-A molecules the existence of three distinct subsets, CD11clowB220,
CD11clowB220, and CD11chigh DCs in both BALB/c andon CD11chighCD45RB DCs. These results show that IL-
10 induces the differentiation of a distinct subset of C57Bl/6 mice (Figure 3A). To further characterize these
different DC subsets, we analyzed the expression of aDCs characterized by the specific high expression of
CD45RB that displays an immature-like phenotype that set of previously described DC markers on the sorted
CD11clowB220, CD11clowB220, and CD11chigh DC pop-cannot be modified by the stimulation with LPS.
ulations from BALB/c (Figure 3B) or C57Bl/6 (data not
shown) mice. Again, the IL-10-derived DC subset, whichIsolation of the Natural Counterpart
represents the CD11clowB220 DCs expressed specifi-of IL-10-Derived DCs
cally high levels of CD45RB, whereas the CD11clowB220We therefore addressed the influence of IL-10 in vivo on
subset, which has been described as plasmacytoid DCs,the differentiation of DCs. Enriched splenic DCs isolated
expressed low levels of CD45RB. CD11clowCD45RBhighfrom IL-10 Tg, IL-10/, syngeneic BALB/c, or C57Bl/6
B220 DCs expressed intermediate levels of CD11b,mice were analyzed for the expression of CD11c (Figure
CD4, and DEC 205 and no CD8, B220, Gr-1, and IgK2A). In IL-10 Tg mice, we observed a higher number of
light chain, a phenotype which clearly showed that theyDCs expressing low levels of CD11c as compared to
were different from plasmacytoid CD11clowB220, orBALB/c mice (Figure 2A). Similar to the CD11clow DCs
classical CD8CD11chigh CD11b DCs, and that they diddifferentiated in vitro in the presence of IL-10, the splenic
not represent another B cell or T cell subpopulation.CD11clow DCs highly expressed the CD45RB marker
We have shown above (Figures 1C and 2D) that LPS(Figure 2B). Moreover, both in vitro IL-10-derived DCs
stimulation did not modify the immature-like phenotypeand splenic CD11clowCD45RBhigh DCs showed plasm-
of CD11clowCD45RBhigh DCs; we therefore tested the ef-acytoid morphology (Figure 2C, 1) in contrast to
fect of CpG ODN stimulation on the phenotypes ofCD11chighCD45RB DCs (Figure 2C, 3). After maturation
CD11clowB220, CD11clowB220, and CD11chigh DCs iso-with LPS, both populations of splenic DCs differentiated
lated from BALB/c mice. Figure 3C shows that CpG ODNinto DCs with long dendrites (Figure 2C, 2 and 4). In
stimulation induced the maturation of B220 plasmacy-contrast to the results obtained in IL-10 Tg mice, the
toid DCs as previously reported (Asselin-Paturel et al.,analysis of CD11clowCD45RBhigh DCs in IL-10/ did not
2001; O’Keeffe et al., 2002), whereas it did not modify thereveal a specific breakdown of this DC subset (Figures
immature-like phenotype of CD11clowCD45RBhighB2202A and 2B) suggesting that IL-10 is not absolutely re-
DCs, showing that these DCs have a stable phenotypequired for the differentiation of CD11clowCD45RBhigh DCs
with low expression levels of MHC class II and CD86but rather specifically enhances it.
after activation with LPS or CpG ODN.We next examined the expression of MHC molecules
The specific function of each DC subset is also dic-I-A and costimulatory molecules CD80 and CD86 on
tated by distinct cytokine profiles. In a first set of experi-FACS-sorted CD11clowCD45RBhigh and CD11chighCD45RB
ments, we analyzed by quantitative RT-PCR the relativesplenic DC subsets from IL-10 Tg, control BALB/c, or
expression of several important cytokines on freshlyC57Bl/6 mice. As shown in Figure 2D, we observed that
sorted or LPS-activated CD11clowCD45RBhigh andex vivo purified CD11clowCD45RBhigh DCs expressed low
CD11chighCD45RB DCs obtained after depletion withlevels of MHC class II, CD80, and CD86 molecules, as
anti-B220 and anti-Gr-1 antibodies. After activation withcompared to CD11chighCD45RB DCs. Moreover, after
LPS, CD11clowCD45RBhigh DCs secreted IL-10 whereasin vitro maturation with LPS, CD11clowCD45RBhigh DCs
CD11chighCD45RB DCs secreted IL-12. Both popula-still retained poor expression levels of MHC class II and
tions secreted IL-1, which was further enhanced byCD86 molecules, suggesting that their immature-like DC
LPS activation, but did not secrete IFN-, even afterphenotype is stable except for an enhanced expression
activation for 24 hr with LPS (Figure 3D). We then mea-of the CD80 molecule, in contrast to the CD11chighCD45RB
sured by ELISA the secretion of IL-10 and IFN- onDCs (Figure 2D). Altogether, these results showed that
freshly isolated, LPS-stimulated or CpG ODN-stimulatedCD11clowCD45RBhigh DCs isolated from the spleen repre-
CD11clowB220, CD11clowB220, and CD11chigh DC pop-sent the in vivo counterpart of the IL-10-derived DCs.
ulations from BALB/c mice (Figure 3E). Again, after LPS
activation, high IL-10 secretion was detected in thePhenotypic Characterization and Comparison
CD11clowCD45RBhighB220 population as compared toof CD11clowCD45RBhigh DC Subset with IFN-
the B220 or CD11chighCD45RB populations. CpG ODNSecreting B220 Plasmacytoid DCs
stimulation induced high levels of IFN- in the B220As mentioned above, another population of DCs with
population as previously reported (O’Keeffe et al., 2002),plasmacytoid morphology has been previously de-
whereas it had no significant effect on the CD11chighscribed. These plasmacytoid DCs secrete high levels of
CD45RBpopulation and induced a slight but significantIFN- after viruses or CpG ODN activation and specifi-
amount of IL-10 in the CD11clowCD45RBhigh population.cally express B220 and Gr-1 (Asselin-Paturel et al.,
These results showed that CD11clowCD45RBhighB2202001). In our experiments, these cells were depleted
from our purified DCs as we used, according to the most DCs represent a distinct subset of DCs that predom-
Immunity
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Figure 4. CD11clowCD45RBhigh DCs Induce
the Differentiation of Regulatory Tr1 Cells In
Vitro
(A) CD11clowCD45RBhigh DCs process and
present antigen in vitro. A Th1 cell population
from DO11-10 mice was stimulated without
APCs (gray bars) or with sorted CD11clow
CD45RBhigh (black bars) or CD11chighCD45RB
(white bars) DCs in the presence of OVA pep-
tide (0.6M) or OVA protein (500 or 250g/ml
as indicated). Proliferative response or IFN-
secretion was analyzed after stimulation at
72 or 48 hr, respectively. Results represent
the mean of triplicate determinations and are
expressed in ng/ml for IFN-. Data are repre-
sentative of two separate experiments with
similar results.
(B) Analysis of cytokines secreted by CD4
T cell populations activated with ex vivo
sorted DCs. Naive OVA TCR transgenic
T cells were differentiated for 3 weeks with
sorted CD11chighCD45RB (white bars) or
CD11clowCD45RBhigh (black bars) DCs in the
presence of OVA peptide. DCs were isolated
from BALB/c mice and mixed at different
DC/T ratios as indicated. Differentiation of
T cells was also performed in the presence
of anti-IL-10 (10 g/ml) at a 1/20 ratio (gray
bars). After the 3 weeks culture, T cells were
collected and stimulated with irradiated
BALB/c splenocytes and OVA peptide (0.3
M). Forty-eight hours later, cytokines were
analyzed by ELISA. Results represent the
mean of triplicate determinations and are ex-
pressed in ng/ml. Data is representative of
five separate experiments with similar results.
(C) Cytokines secreted by CD4 T cell popu-
lations differentiated with in vitro-derived
DCs. DCs were obtained from cultures of
bone marrow cells with GM-CSF and TNF-
and IL-10 (500 ng/ml). DCs were sorted into
CD11chighCD45RB and CD11clowCD45RBhigh
DC subsets. Sorted DCs were used to differ-
entiate DO11-10 naive CD4 T cells, at 1:20
DC/T ratio in the presence of OVA peptide
(0.6 M). After 1 week, T cells were collected
and stimulated with irradiated splenic APCs
and OVA peptide (0.3 M). Forty-eight hours
later, cytokines were analyzed by ELISA. Re-
sults represent the mean of triplicate determi-
nations and are expressed in ng/ml. Data are
representative of two separate experiments
with similar results.
(D) Intracellular cytokine assay for naive DO11-10 T cells stimulated with OVA peptide and sorted CD11clowCD45RBhigh or CD11chighCD45RB
DCs. Both DC subsets were isolated from BALB/c mice, FACS sorted, and cocultured with naive DO11-10 T cells in the presence of OVA
peptide. Seven days later, cells were stimulated and stained for intracellular cytokine assay using FITC- or PE-conjugated specific mAbs as
indicated. One representative experiment out of three is shown.
(E) Regulatory function of T cells differentiated with CD11clowCD45RBhigh DCs. In the bottom well of a transwell system, purified CD4 T cells
isolated from BALB/c mice were stimulated with irradiated BALB/c splenocytes and anti-CD3 mAbs (white bars). In the upper compartment,
CD4 T cells differentiated by a single stimulation with either CD11clowCD45RBhigh DCs or CD11chighCD45RB DCs were stimulated with OVA
peptide and irradiated splenocytes. Coculture experiments were also performed in the presence of blocking mouse anti-IL-10 mAb (10 g/
ml) (white crosshatched bars), mouse anti-TGF- mAb (40 g/ml) (black bars), or both (gray bars). Three days later, the basket was removed
and the proliferative response of the bystanders CD4 T cells was measured after a pulse with 0.5 Ci of 3H-thymidine during the final 12 hr
of the 72 hr culture. Results represent mean SD of triplicates from one representative experiment out of three.
inantly secrete IL-10 after activation with LPS or to stimulate a Th1 cell population. Analysis of the prolif-
CpG ODN. erative response and IFN- secretion showed that both
sorted CD11clowCD45RBhigh and CD11chighCD45RB DCs
processed and present the ovalbumin protein to stimu-CD11clowCD45RBhigh DCs Differentiate
Tr1 Cells In Vitro late an OVA-specific T cell population, although the
CD11chighCD45RB DCs induced a more vigorous prolif-First, to analyze the ability of CD11clowCD45RBhigh DCs
to process and present antigens, we tested their ability eration than the CD11clowCD45RBhigh DCs (Figure 4A). To
Tolerogenic DCs that Differentiate Tr1 Cells
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Figure 5. CD11clowCD45RBhigh DCs Induce the Differentiation of Tr1 Cells In Vivo
Sorted CD11clowCD45RBhigh or CD11chighCD45RB DCs isolated from BALB/c mice were loaded with OVA peptide in vitro and injected intraven-
eously into mice previously transferred with OVA peptide-specific T cells. One week later, proliferative response (A) and cytokine production
(B) of splenic CD4 T cells stimulated with OVA peptide (0.3 M) and irradiated splenic APCs were tested. For cytokine measurements, results
represent means of triplicate determinations and are expressed in ng/ml. Data are representative of three separate experiments with similar
results.
analyze the influence of the different DC subsets on the cytes and anti-CD3 mAb (Figure 4E). Furthermore, the
addition of blocking mouse anti-IL-10 and anti-TGF-priming and differentiation of naive OVA specific T cells,
multiple rounds of stimulations of T cells were estab- mAbs reverted the suppressive effect of these T cells,
confirming the differentiation of Tr1 cells both phenotyp-lished with sorted CD11clowCD45RBhigh or CD11chigh
CD45RB DCs isolated from the spleen of BALB/c mice ically and functionally (Figure 4E). As a control, Th1 cell
populations (induced by CD11chighCD45RB DCs) had(Figure 4B) or differentiated in vitro in the presence of
IL-10 (Figure 4C). Our results showed that both ex vivo no inhibitory effect (Figure 4E). Altogether, these results
showed that CD11clowCD45RBhigh DCs induced the differ-purified or in vitro differentiated CD11clowCD45RBhigh
DCs, regardless of the DC/T ratio used, induced the entiation of Tr1 cells in vitro.
differentiation of Tr1 cells which secreted high levels of
IL-10, low levels of IFN-, and no or negligible amounts CD11clowCD45RBhigh DCs Induce Antigen-Specific
Tolerance In Vivoof IL-4 (Groux et al., 1997) (Figures 4B and 4C). In con-
trast to CD11clowCD45RBhigh DCs, CD11chighCD45RB To analyze the in vivo function of CD11clowCD45RBhigh
DCs, we used a mouse model where naive splenic CD4DCs primed Th1 cells which secreted high levels of IFN-
(Figures 4B and 4C). As a control, we also tested the OVA-specific T cells from DO11-10 mice were trans-
ferred into normal BALB/c mice. These transferred micefunction of in vitro-derived DCs cultured in the absence
of IL-10; as expected the CD11chighCD45RB population were then treated with purified subsets of DCs pulsed
with OVA peptide in vitro. One week later, we measuredinduced the differentiation of Th1 cells (data not shown),
whereas not enough CD11clowCD45RBhigh DCs were ob- the proliferative response and the secretion of cytokines
in response to OVA peptide stimulation of purifiedtained to test their function. Altogether, these results
are correlated with the cytokine profile of the DC sub- splenic CD4 T cells from the transferred mice. Similar
to the results obtained in vitro, Figure 5 shows thatpopulations, i.e., CD11clowCD45RBhigh DCs, which dif-
ferentiate Tr1 cells and secrete IL-10, whereas IL-12 the injection of CD11clowCD45RBhigh DCs induced the
differentiation of OVA peptide-specific Tr1 cells in vivo.secreted by CD11chighCD45RB DCs induces the differ-
entiation of Th1 cells. These cells were characterized by a poor proliferative
response (Figure 5A) and a high secretion of IL-10 (Fig-Moreover, the specific differentiation of Tr1 cells with
the CD11clowCD45RBhigh DCs was observed after a single ure 5B). As a control, the injection of OVA peptide-pulsed
CD11chighCD45RB DCs induced the differentiation ofstimulation as shown by the intracytoplasmic analysis
of cytokine secretion in the different T cell populations T cells with a high proliferative response and a high
secretion of IFN-.(Figure 4D). The phenotype of these Tr1 cells was highly
stable as even when restimulated with CD11chigh We therefore analyzed the ability of CD11clowCD45
RBhigh DCs to induce tolerance in vivo. Sorted CD11clowCD45RB DCs, a situation that is likely to occur in vivo,
they conserved their cytokine profile (data not shown). CD45RBhigh or CD11chighCD45RB DCs, either isolated
from the spleen of BALB/c mice or obtained after in vitroTo analyze the functional properties of these Tr1 cells,
transwell experiments were performed. T cells obtained differentiation in the presence of IL-10, were pulsed with
OVA peptide and injected into naive OVA-specific T cell-after a single stimulation with CD11clowCD45RBhigh DCs
from BALB/c mice suppressed the proliferation of by- transferred BALB/c mice. One week later, tolerance in-
duction was challenged by two 15 day interval immuni-stander CD4 T cells stimulated with irradiated spleno-
Immunity
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Figure 6. CD11clowCD45RBhigh DCs Induce Tolerance In Vivo
Sorted CD11clowCD45RBhigh or CD11chighCD45RB DCs either isolated from BALB/c mice or differentiated in vitro as indicated were loaded
with OVA peptide in vitro and injected intraveneously into mice previously transferred with OVA peptide-specific T cells. One week later, mice
were immunized with OVA/alum, TT/alum, or OVA/CFA and boosted 2 weeks later. Mice were analyzed 4 weeks after the first immunization.
(A) OVA-specific (plain bars) or TT-specific (striped bars) IgG1 and IgE were measured by ELISA on pooled sera from each group of five mice
immunized with OVA or TT in alum and expressed as means of triplicate assays. One representative experiment out of three is shown.
(B) OVA-specific IgG1 and Ig2a were measured by ELISA on pooled sera from each group of five mice immunized with OVA in CFA and
expressed as means of triplicate assays.
(C) Sorted CD11clowB220 or CD11clowB220 DCs isolated from normal BALB/c mice were loaded with OVA peptide in vitro and injected
intraveneously into mice previously transferred with OVA peptide-specific T cells. Mice were immunized with OVA/alum 1 week later and were
Tolerogenic DCs that Differentiate Tr1 Cells
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Figure 7. CD4 T Cells Isolated from Mice
Tolerized with CD11clowCD45RBhigh DCs Are
Able to Transfer the Tolerance to the Antigen
BALB/c mice transferred with naive OVA-
specific T cells were treated with CD11clow
CD45RBhigh DCs pulsed with OVA peptide. As
a control, some mice were transferred with
naive T cells alone. One week after transfer,
splenic purified CD4 T cells from injected
mice were adoptively transferred into normal
BALB/c mice. As indicated, untreated mice
or mice transferred with purified CD4 T cells
were then immunized with OVA/alum. Immu-
nization was boosted 2 weeks later, and mice
were analyzed 4 weeks after the first immuni-
zation.
(A) OVA-specific IgG1 were measured by
ELISA on pooled sera from each group of five
mice and expressed as means of triplicate
assays. One representative experiment out of
three is shown.
(B) Purified splenic CD4 T cells from trans-
ferred and immunized mice were stimulated
in vitro with OVA protein (250 g/ml) (black
bars) or medium alone (white bars). The prolif-
erative response was measured by 3H-thymi-
dine incorporation during the last 12 hr of a
72 hr culture. Data are representative of three
separate experiments.
(C) Forty-eight hours after restimulation, as
described in (B), culture supernatants were
collected and cytokines were measured by
ELISA. Results represent means of triplicate
determinations and are expressed in ng/ml.
Data are representative of three separate ex-
periments with similar results.
zations, with the whole ovalbumin protein in alum or after immunization with OVA in alum, a marked reduced
response was observed in mice treated with ex vivoCFA. Two weeks after the last immunization, analysis
of serum OVA-specific IgE and IgG1 for alum immuniza- purified CD11clowB220(CD45RBhigh) DCs, as compared
to control or CD11clowB220 DC treated mice, support-tion or IgG1 and IgG2a for CFA immunization revealed
a marked reduced response in mice treated with in vitro- ing a specific role of the CD11clowCD45RBhigh DCs in
inducing antigen-specific tolerance as compared todifferentiated or ex vivo purified CD11clowCD45RBhigh
DCs, as compared to control immunized mice (Figures other DC subpopulations.
The induction of tolerance was confirmed by the anal-6A and 6B) in both types of immunization. Injection of
OVA-pulsed CD11chighCD45RB DCs boosted the Th1- ysis of the proliferative response to ovalbumin of CD4
T cells isolated from the spleen of immunized mice.type response (especially the IgG2a response) after the
immunization with CFA (Figure 6B), but their priming Indeed, CD4 T cells isolated from mice treated with
CD11clowCD45RBhigh DCs proliferated poorly after stimu-effect (as observed in Figure 5) was minimized after the
Th2-mediated responses induced by the alum immuni- lation with ovalbumin as compared to the proliferative
response of CD4 T cells isolated from the spleen ofzation (Figure 6A). The induction of tolerance was anti-
gen specific as the immunization with tetanus toxoid immunized mice previously untreated or treated with
CD11chighCD45RB or B220 DCs (Figure 6D). Finally,(TT) in alum induced the same amount of TT-specific
antibodies in the sera of mice treated or not with the analysis of cytokine secretion by splenic CD4
T cells confirmed the induction of tolerance. Immuniza-CD11clowCD45RBhigh DCs (Figure 6A). In similar experi-
ments, we also compared the in vivo effects of tion of mice with ovalbumin in alum resulted in a Th2-
like response with a high IL-4 and a low IFN- secretionCD11clowB220 and B220 DCs obtained after depletion
with anti-CD3 and anti-CD19. As shown in Figure 6C, (Figure 6E). In contrast, in mice treated with CD11clow
boosted 2 weeks later. Mice were analyzed 4 weeks after the first immunization. OVA-specific IgG1 were measured by ELISA on pooled sera
from each group of five mice and expressed as means of triplicate assays.
(D) Purified splenic CD4 T cells, from mice immunized with OVA/alum (plain bars) or TT/alum (striped bars), were stimulated in vitro with
OVA protein (250 g/ml). The proliferative response was measured by 3H-thymidine incorporation during the last 12 hr of a 72 hr culture. Data
are representative of three separate experiments.
(E) Forty-eight hours after restimulation, as described in (D), culture supernatants were collected and cytokines were measured by ELISA.
Results represent means of triplicate determinations and are expressed in ng/ml. Data are representative of three separate experiments with
similar results.
Immunity
614
CD45RBhigh DCs, T cells secreted low amounts of IFN- (data not shown) and characterized by low expression
levels of CD11c, CD11b, and DEC-205 and no expres-and IL-4 and some IL-10.
sion of Gr-1, CD8, and B220. This phenotype and the
percentage of cells in the different tissues analyzed ap-Tolerance Induced by CD11clowCD45RBhigh DCs
pear similar to the myeloid CD4CD8CD205CD11bIs Transferable with Splenic CD4 T Cells
population of DCs previously described (Shortman andOur results suggest that CD11clowCD45RBhigh DCs induce
Liu, 2002). Moreover, although they have the typicaltolerance through the differentiation of antigen-specific
morphology of plasmacytoid cells, CD11clowCD45RBhighTr1 cells in vivo. Therefore, we next evaluated whether
tolerogenic DCs are different from the B220 plasmacy-splenic CD4 T cells isolated from mice exposed to
toid cells which secrete IFN- (Asselin-Paturel et al.,CD11clowCD45RBhigh DCs had the capacity to transfer
2001; O’Keeffe et al., 2002). The CD11clowCD45RBhigh tol-tolerance. CD11clowCD45RBhigh DCs isolated from the
erogenic DCs are distinct from B220 DCs by the ab-spleen of BALB/c mice, pulsed with OVA peptide in vitro,
sence of IFN- secretion after activation with CpG ODNwere injected into naive OVA-specific T cell-transferred
and a specific high secretion of IL-10. Moreover, whilemice. Seven days later, purified splenic CD4 T cells
activation with LPS and CpG ODN enhances expressionwere adoptively transferred into untreated BALB/c mice.
of MHC class II and costimulatory molecules on humanTo assess for tolerance induction, transferred mice were
and mouse IFN- secreting plasmacytoid DCs (Liu etsubsequently immunized twice with OVA/alum. Figure
al., 2001), no CD86 and MHC class II molecules were7 shows that mice transferred with CD4 T cells isolated
induced on CD11clowCD45RBhigh tolerogenic DCs afterfrom mice treated with tolerogenic CD11clowCD45RBhigh
activation with LPS or CpG ODN. This discrepancy isDCs were unable to mount a correct immune response
also consistent with their different functions in vitro asto antigenic challenge, as measured by OVA-specific
IFN--secreting plasmacytoid DCs have been shown inantibodies in the serum and poor recall response in vitro.
several reports to induce the differentiation of effectorIndeed, CD4 T cells isolated from these mice displayed
T cells, either Th2 (Rissoan et al., 1999) or Th1 (Cella eta low proliferative response to stimulation with the anti-
al., 2000), based on the different microenvironments andgen (Figure 7B) and a modest secretion of IL-4 and
types of activation, whereas CD11clowCD45RBhigh tolero-IFN-, as compared to control mice (Figure 7C). How-
genic DCs induce the differentiation of Tr1 cells.ever, CD4 T cells isolated from tolerant mice secreted
The observation that tolerogenic DCs secrete IL-10higher levels of IL-10 (Figure 7C). These results showed
may be linked to the stability of their immature-like phe-that CD11clowCD45RBhigh DCs induced tolerance through
notype. IL-10 has been shown to inhibit MHC class IIthe differentiation of antigen-specific regulatory T cells
and costimulatory molecules on APCs (Ding et al., 1993;that transferred tolerance to normal mice.
Koppelman et al., 1997), and, in vitro, the addition of IL-
10 onto bone marrow precursors allows enrichment inDiscussion
DCs expressing CD11clowCD45RBhigh markers in popula-
tions differentiated in the presence of GM-CSF. In theIn this study, we describe a population of tolerogenic
absence of IL-10, the population of DCs differentiated
DCs characterized by a low expression level of CD11c
with GM-CSF has a very low percentage of DCs express-
and the selective high expression of CD45RB. These
ing the CD45RB marker (1%), whereas these cells rep-
DCs are highly potent to induce tolerance as a single
resent approximately 30% of the cells in the presence
injection of 3 	 105 OVA peptide-pulsed CD11clow of IL-10. The fact that IL-10 acts by a direct effect on
CD45RBhigh DCs is sufficient to dramatically decrease the differentiation of tolerogenic DCs and not by the
the ability of the treated mice to mount a T and B cell- inhibition of the differentiation of other populations is
mediated immune response directed against the whole supported by the observation that equivalent numbers
ovalbumin protein in the presence of different adjuvants. of cells were recovered, even when TNF- was added
Moreover, our results show that the induction of toler- to enhance the yield and survival of DCs. Moreover, the
ance induced by CD11clowCD45RBhigh DCs is mediated positive effect of IL-10 on the differentiation of tolero-
by the differentiation of regulatory Tr1 cells. In vitro, a genic DCs was confirmed in IL-10 Tg mice where higher
single stimulation of naive T cells with CD11clowCD45 proportions of these CD11clowCD45RBhigh tolerogenic
RBhigh tolerogenic DCs induces the differentiation of DCs were observed in the spleen. However, if IL-10
T cells characterized by the secretion of high levels of appears to enhance the differentiation of CD11clow
IL-10, some IFN-, no IL-2, and no IL-4. Moreover, in CD45RBhigh tolerogenic DCs, the analysis of IL-10/
vitro functional assays using a transwell system have mice DCs suggests that IL-10 is not absolutely required
confirmed the differentiation of Tr1 cells. In vivo, the for the differentiation of these tolerogenic DCs and that
treatment of mice with OVA peptide-pulsed CD11clow other pathways could be used for their differentiation
CD45RBhigh tolerogenic DCs also induced the differentia- in the absence of IL-10.
tion of antigen-specific Tr1 cells characterized by their Until now, immature DCs were thought to induce T cell
cytokine profile (Figure 5). Indeed, the ability to transfer anergy or regulatory T cells (Jonuleit et al., 2000; Lutz
tolerance from mice treated with the CD11clowCD45RBhigh et al., 2000) whereas the same cells, transformed after
tolerogenic DCs to normal mice with the purified CD4 stimulation into immunogenic mature DCs, represented
T cells indicates that the differentiation of Tr1 cells in the unique inducers of effector T cells (Banchereau and
vivo accounts for the observed induction of tolerance Steinman, 1998). However, several reports have de-
(Figures 6 and 7). scribed populations of mature (or not fully immature)
The CD11clowCD45RBhigh tolerogenic DCs represent a DCs that induce tolerance in vivo (Akbari et al., 2001;
McGuirk et al., 2002; Menges et al., 2002). These datasubset of DCs, located in the spleen and lymph nodes
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ditions and were 4- to 8-week-old females at the beginning of eachchallenge the bimodal concept and raise the question
experiment.of the true nature of tolerogenic DCs and the mecha-
nisms of tolerance induced by these different popula-
tions of DCs, deletion, anergy, or active suppression. Medium, Antibodies, and Reagents
Immature DCs are resident resting sentinel cells present The medium used for T cell cultures was Yssel medium (Yssel et
al., 1984). DCs were cultured in RPMI 1640 supplemented with 10%in peripheral tissues that endocytose apoptotic materi-
FCS (Roche, Meylan, France), 2 mM L-Glutamine, 1% sodium py-als. However, endocytosis alone does not induce matu-
ruvate, 2 	 105 M 2 mercaptoethanol all from Invitrogen (Cergy-ration and migration of these cells (Rubartelli et al.,
Pontoise, France).
1997). Therefore, DCs remain immature and tissue resi- Recombinant mouse GM-CSF, TNF-, and IFN- were purchased
dent, and express low amounts of MHC class II mole- from R&D Systems (Abington, United Kingdom). Recombinant
cules and no costimulatory molecules, a condition that mouse IL-10 and IL-4 were a generous gift from Dr. R.L. Coffman,
DNAX. Recombinant mouse IFN-was obtained from PBL Biomedi-leads to T cell anergy. However, spontaneous migration
cal Laboratories (New Brunswick, NJ).of DCs is also observed under healthy, steady-state
Anti-CD3 (17A2), anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-CD11bconditions. These steady-state migrating DCs, loaded
(M1/70), anti-CD11c (HL3), anti-CD19 (1D3), anti-CD28 (37.51), anti-
with self- and commonly encountered antigens, are ob- I-Ad (AMS-32.1), anti-I-Ab (AF6-120.1), anti-CD62L (Mel-14), anti-
served in different tissues like the skin (Hemmi et al., CD80 (16-10A1), anti-CD86 (GL1), anti-B220 (RA3-6B2), CD45RB
2001), the vagina, and cervix (Parr et al., 1991), the gut (16A), anti-Gr1 (RB6-8C5), anti-IgK (187.1) (all from Pharmingen Bec-
ton Dickinson, le Pont de Claix, France), and DEC-205 (NLDC-145)(Huang et al., 2000), or the lung (Akbari et al., 2001) and
(Serotec, United Kingdom) were used for purification and character-have been shown to induce tolerance in vivo (Akbari
ization of DCs.et al., 2001). These migrating DCs are different from
For cytokine assays, we used anti-IL-4-PE or -FITC (11B11), anti-
immature DCs. First, they downregulate the expression IFN--PE (XGM1.2), anti-IL-10-FITC (JES5-16E3), anti-IL-4 (11B11),
of chemokine receptors expressed by immature DCs anti-IL-10 (2A5), anti-IFN- (XGM1.2), biotin anti-IL-4 (24G2), anti-
(CCR5, CCR6) and gain expression of CCRs that drive IL-10 (SXC1), anti-IFN- (R4-6A2) (Pharmingen Becton Dickinson),
anti-IFN- (RMMA-1), and rabbit anti-mouse-IFN- (PBL Biomedicaltheir migration to lymphoid tissues (CXCR4 and CCR7)
Laboratories).(Allavena et al., 2000). Indeed, we observed that
Anti-IgE (R35-72), anti-IgG1 (A85-1), and anti-IgG2a (R19-15) usedCD11clowCD45RBhigh tolerogenic DCs express CCR7 and
for analysis of OVA-specific Ig were from Pharmingen Becton Dick-
CXCR4 (data not shown). Moreover, transport, pro- inson.
cessing, and presentation for tolerance induction re- Lysis buffer, saponin, metrizamide, LPS, OVA 323-339 peptide, oval-
quire maturation signals to partially enhance upregula- bumin, alum, and Complete Freund’s Adjuvant (CFA) were from
Sigma (Saint Quentin Fallavier, France). Tetanus toxin was a gifttion of MHC and costimulatory molecules (Allavena et
from H. Yssel (INSERM U454, France). CpG oligodeoxynucleotide-al., 2000). These maturation signals are obviously differ-
1668, 5
-TCCATGACGTTCCTGATGCT-3
, was obtained from MWG-ent from microbial or inflammatory stimuli that induce
Biotech AG Ebersberg (Germany). Brefeldin A was purchased from
the differentiation of other types of DCs expressing high Molecular Probes (Leiden, The Netherlands).
levels of MHC and costimulatory molecules and secre-
ting IL-12. Our results suggest that IL-10 could be one
DCs Derived from Bone Marrowof these maturation signals that drives the differentiation
DCs derived from bone marrow (BM-DCs) were generated fromof tolerogenic DCs with an intermediate phenotype
bone marrow cells, as described (Inaba et al., 1992). Cells werecalled semimature (Lutz and Schuler, 2002) or quiescent
cultured in complete RPMI medium supplemented with 10 ng/ml
(Shortman and Liu, 2002). Altogether, our results sug- GM-CSF and 2.5 ng/ml TNF- with or without IL-10 (10 to 500 ng/
gest that CD11clowCD45RBhigh DCs represent a popula- ml). BM-DCs were harvested on day 6.
tion of DCs that have matured to display a stable tolero-
genic phenotype with a unique molecular design by the
Purification of Splenic DCsdownregulation of T cell activation partners. Under
Spleens were cut into small fragments and digested with collage-
steady-state conditions, these cells, loaded with self- nase D (1 mg/ml) in HBSS for 20 mn at 37C. The cells were then
and commonly encountered antigens, are driven to layered over RPMI 1640/14.5% metrizamide and centrifuged for 10
lymphoid organs by endogenous factors to induce the mn at 600 g. T cells, B cells, and granulocytes were depleted by
treating the recovered low-density cells for 30 mn at 4C with adifferentiation of Tr1 cells and tolerance.
monoclonal antibody mixture containing anti-CD3, anti-B220, andFinally, the ability to isolate tolerogenic DCs opens
anti-Gr-1 or alternatively anti-CD3, anti-CD19, and anti-rat Ig-coatednew therapeutic perspectives for the use of tolerogenic
magnetic beads.
DCs in autoimmune/inflammatory diseases and alloge-
neic transplantation. Indeed, in vitro pulsing of tolero-
genic DCs with self- or alloantigens followed by in vivo Differentiation of TCR Transgenic T Cells by DCs
Naive CD4 T cells from DO11.10 OVA TCR transgenic mice wereinjection could lead to the specific differentiation of reg-
prepared as described (Groux et al., 1997). Primary stimulation cul-ulatory T cell populations able to downregulate self/
tures were established by activation of purified naive CD4 T cellsalloreactivity mediated by both Th1 or Th2 T cells.
(2.5 	 105) with sorted DC populations pulsed with the OVA 323-339
peptide (0.6 M). After one week, cells were restimulated with fresh
sorted DC populations plus 0.3 M of the OVA peptide. The sameExperimental Procedures
procedure was performed for the third differentiation round. After
differentiation, T cells were restimulated with 0.3 M OVA 323-339 andMice
Homozygous DO11-10 mice were a generous gift from Dr. S.D. Hurst irradiated total splenic APCs. Proliferation of T cells was assayed
by incorporation of 3H-thymidine during the last 12 hr of the 72 hr(DNAX, Palo Alto, CA). BALB/c IL-10 Tg mice were described (Groux
et al., 1999). BALB/cAnN, C57Bl/6, and C57Bl/6 IL-10/ mice were incubation. The production of IL-4, IL-10, and IFN- was measured
by ELISA in supernatants collected at 48 hr. Transwell experimentspurchased from Charles River Laboratory (IFFA CREDO, L’Arbresle,
France). All mice were raised in common mouse pathogen-free con- were performed as described (Groux et al., 1997)
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